Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calcula Technologies is a private medical device company focused on urology, developing tools for the treatment and removal of kidney and ureteral stones. Its lead known product is the Peralta Stone Removal Catheter, an endoscopic device intended to grasp, manipulate, and remove calculi from the urinary tract and also support ureteral dilation. The company received FDA 510(k) clearance for the Peralta Stone Removal Catheter and announced successful completion of its initial clinical cases after clearance. Calcula appears to be an early-stage, revenue-generating health technology company rather than a therapeutics developer, with activity centered on interventional stone-management devices used outside traditional operating-room workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calcula Technologies.